ARTICLE | Management Tracks
McDonnell now CEO of Agilent
Plus: Dubensky to lead ImmuneSensor and updates from NORD and Epsilogen
May 2, 2024 12:34 AM UTC
Padraig McDonnell is now CEO of Agilent Technologies Inc. (NYSE:A), having been named CEO-elect in February when he was COO. McDonnell joined Agilent in 1997 and succeeds Mike McMullen, who will serve as an adviser until he retires on Oct. 31.
ImmuneSensor Therapeutics Inc. named Thomas Dubensky president and CEO. Dubensky was the founding CEO of Tempest Therapeutics Inc. (NASDAQ:TPST). ImmuneSensor, which debuted May 1, is targeting the cGAS-STING pathway to treat indications in inflammation, autoimmunity and oncology...